Super-Assembled Periodic Mesoporous Organosilica Frameworks for Real-Time Hypoxia-Triggered Drug Release and Monitoring

ACS Appl Mater Interfaces. 2021 Oct 27;13(42):50246-50257. doi: 10.1021/acsami.1c15067. Epub 2021 Oct 12.

Abstract

Hypoxia, induced by inadequate oxygen supply, is a key indication of various major illnesses, which necessitates the need to develop new nanoprobes capable of sensing hypoxia environments for the targeted system monitoring and drug delivery. Herein, we report a hypoxia-responsive, periodic mesoporous organosilica (PMO) nanocarrier for repairing hypoxia damage. β-cyclodextrin (β-CD) capped azobenzene functionalization on the PMO surface could be effectively cleaved by azoreductase under a hypoxia environment. Moreover, the nanosystem is equipped with fluorescence resonance energy transfer (FRET) pair (tetrastyrene derivative (TPE) covalently attached to the PMO framework as the donor and Rhodamine B (RhB) in the mesopores as the receptor) for intracellular visualization and tracking of drug release in real-time. The design of intelligent nanocarriers capable of simultaneous reporting and treating of hypoxia conditions highlights a great potential in the biomedical domain.

Keywords: Förster resonance energy transfer (FRET); controlled release; hypoxia-responsive; periodic mesoporous organosilica; real-time monitoring.

MeSH terms

  • Cell Line, Tumor
  • Drug Carriers / chemical synthesis
  • Drug Carriers / chemistry
  • Drug Carriers / pharmacology
  • Drug Liberation
  • Humans
  • Hypoxia / drug therapy*
  • Hypoxia / metabolism
  • Materials Testing
  • Molecular Structure
  • Organosilicon Compounds / chemical synthesis
  • Organosilicon Compounds / chemistry
  • Organosilicon Compounds / pharmacology*
  • Particle Size
  • Porosity
  • Surface Properties
  • Time Factors

Substances

  • Drug Carriers
  • Organosilicon Compounds